ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville
Helix at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Helix brings 9 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1200. Its program centres on population-scale genomic screening, clinical genetics, and therapeutic research using clinico-genomic data. Its presentations cover three-year outcomes of screening 527,000 participants for CDC Tier 1 conditions, rare GLP1R variants affecting semaglutide weight loss, and pharmacogenomic testing that reverses excess clopidogrel hospitalizations.
| Organization | ASHG 2026 Attendance |
|---|---|
Helix San Mateo, California | 2 Senior Research Scientist · 1 Medical Director · 1 Associate Director Research · 1 Senior Staff Scientist |
Helix sells population-scale genomic testing, clinico-genomic data, and research tools to health systems and life-science companies.
| Booth Exhibiting at Booth 1200 Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm Plenary Tue Oct 20 5:57 pm CDCT1 Screening in 527K Participants: A 3-year Outcomes Study Genetic testingPopulation geneticsClinical geneticsPrecision medicine Talk Wed Oct 21 11:45 am Distinct genetic architectures of kidney function decline quantified by multi-state Markov analysis of 3.4 million serial eGFR measurements across 13 health systems Complex traitsGenetic epidemiologyGenotype-phenotype correlationsPolygenic risk score Talk Thu Oct 22 1:45 pm Rare GLP1R variants selectively attenuate weight loss with semaglutide but not tirzepatide, implicating GIP receptor agonism as a compensatory mechanism PharmacogenomicsRare variantsObesityPrecision medicine Poster Thu Oct 22 4:15 pm APOE genotype shapes the trajectory from mild cognitive impairment to dementia in a large clinical genomics cohort NeurodegenerationElectronic health recordsGenotype-phenotype correlationsPrecision medicine Poster Thu Oct 22 4:15 pm ApoB isoform-specific mechanisms of liver disease in heterozygous pLoF carriers across three population cohorts Clinical geneticsGenetic variationLarge-scale biobanks Poster Fri Oct 23 2:30 pm Plasma proteomics highlights a preclinical cardiomyopathy signature in pathogenic variant carriers without clinical diagnosis Cardiovascular systemMachine learningProteomicsRare variants Poster Fri Oct 23 2:30 pm Plasma proteomic signatures of kidney disease within APOL1 genotype strata in a population genomic screening program Clinical testingGenetic testingMetabolic disorderPrecision medicine Poster Fri Oct 23 2:30 pm CYP2C19 pharmacogenomic testing and intervention reverses excess hospitalization trend for patients taking clopidogrel Pharmacologic therapyPharmacogenomicsGenetic testingClinical genetics Poster Fri Oct 23 2:30 pm Cumulative pharmacogenomic variant burden associates with polypharmacy, treatment inefficacy, and adverse drug events PharmacogenomicsPharmacologic therapyGenetic variationGenotype-phenotype correlations |
Find decision makers at Helix
Tell us what you sell and we’ll find the people at Helix most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction